CPAF- Contract Monitoring 2019/20


Community Pharmacy Assurance Framework (CPAF) – arrangements for 2019/20

To ensure that patients and members of the public receive safe, effective and high quality pharmaceutical services, NHS England has processes in place to monitor compliance by pharmacy contractors, who are included in one of NHS England’s pharmaceutical lists, with the terms of service set out in the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (the 2013 regulations).

One of these processes is the use of the Community Pharmacy Assurance Framework (CPAF) to be conducted in two parts.

Part One - Screening questionnaire

All pharmacy contractors to be invited to complete a short screening questionnaire consisting of ten questions to assure themselves and NHS England that they are compliant with the terms of service.

Part Two - Contract Monitoring visit and full CPAF questionnaire

The data collected from this questionnaire along with other information held by NHS England to be used to shortlist pharmacies to be considered for a contract monitoring visit. Only these pharmacies are asked to complete a full CPAF questionnaire. A copy of the full CPAF can be viewed here.

This approach means that the majority of contractors do not need to complete the full CPAF questionnaire. However, both the Pharmaceutical Services Negotiating Committee (the PSNC) and NHS England recommend that all pharmacy contractors make use of the full CPAF questionnaire to assure themselves that they are compliant with the terms of service.

Process

Pharmacies will be asked to complete the screening questionnaire during June 2019 Please note that the CPAF screening questionnaire was updated in 2018 following development work by the CPAF working group, a working group with membership from NHS England, NHS Business Services Authority (NHSBSA) and the PSNC. The CPAF screening questionnaire again includes the two questions focusing on safeguarding and pharmacy audits; which replaced the questions on ‘owings’ and prescribed medicines advice, which have been retired and no longer need to be answered.

The NHS Business Services Authority (BSA) will carry out the administration of both the screening questionnaire and the full CPAF at a national level on our behalf and this is facilitated through a secure on-line mechanism to allow pharmacy contractors to complete their returns. The screening questionnaire will be available to view in advance from 20 May 2019 and can be found here.

Contractors will have four weeks to complete the screening questionnaire which will be available from Monday 3 June 2019 with a closure date of Sunday 30 June 2019. The questionnaire should only take around 20 minutes to complete.

Contractors will receive information and instructions on how to access and complete the questionnaire from the BSA during week commencing 27th May 2019.

Once you have submitted the completed questionnaire you will have the facility to save, print or access your responses for further reference.

CPAF 2019/20 Process final

Thank you in advance for your cooperation in this exercise.

Please note: LPCs will not be routinely informed of which pharmacies will  be asked to complete full CPAF returns so please email tania@suffolklpc.org.uk if you are notified of the need to complete this and require advice on the completion of this questionnaire.

Contract Monitoring Visits

Within the pharmacist’s terms of service, a pharmacist shall allow persons authorised in writing by NHS England to enter and inspect his pharmacy at any reasonable time for the purpose of ascertaining whether or not the pharmacist is complying with the requirements of their terms of service. Where the pharmacist requests it, the LPC can be present at the inspection.

Any visit should be planned carefully so as not to impact negatively on the day-to-day running of the pharmacy. Patients of pharmacies do not require appointments therefore any inspection teams should not necessarily expect to have the pharmacist devoted to them during any visit, nor should any inspection disrupt the concentration of pharmacy staff in the provision of care to patients.